RADIATION THERAPY ONCOLOGY GROUP
RTOG 1112
RANDOMIZED PHASE III STUDY OF SORAFENIB VERSUS STEREOTACTIC BODY RADIATION THERAPY FOLLOWED BY SORAFENIB IN HEPATOCELLULAR CANCER
RTOG 1112
RANDOMIZED PHASE III STUDY OF SORAFENIB VERSUS STEREOTACTIC BODY RADIATION THERAPY FOLLOWED BY SORAFENIB IN HEPATOCELLULAR CANCER
Protocol Participation Information
- Credentialing Requirements
- Facility Questionnaire: Parts I, II, and III are required for this protocol.
- Download fillable forms and complete them.
- Submit to RTOG RT Quality Assurance Department
Email: rtog-facquest@phila.acr.org Fax: 215-940-8817
- IGRT Immobilization/Localization Systems Test
- IGRT Credentialing for RTOG Protocols
- Submitting IGRT Data to the ITC
- Anonymized Patient Spreadsheet to be submitted with IGRT patient data (rev. 7/11/2012)
- RPC Phantom Dosimetry Test (Liver Phantom)
- Fill out the RPC Phantom Request Form to request shipment of a phantom.
- ITC Digital Data Submission Test
- Please contact Bill Straube at ITC (314-362-9762, itc@wustl.edu) for instructions.
- Benchmark Guidelines - please contact Bill Straube at (314)
362-9762 for details
- Download benchmark dataset and planning instructions.
- Create plan per protocol
- Upload treatment planning data to ITC and submit online DDSI form
- Dose-Volume Analysis Form for evaluation of benchmark cases
- Please be aware that evaluation of benchmark cases may take up to 2 weeks.
- How to Submit Digital Data
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- ATC Compliant Treatment Planning Systems
- Upper Abdominal Normal Organ Contouring Consensus Guidelines
- Structure Names - Please refer to protocol text for structure naming requirements.
- Study Details Page (http://www.rtog.org)
Back to protocols
